Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DREHM Pharma is Austria’s largest consultant and service provider for the pharmaceutical industry, specializing in regulatory affairs, pharmacovigilance, quality management, audits, medical writing, production support including batch certification and EU import. The company does not develop or market its own pharmaceutical products but supports clients across the full product lifecycle with expert advice and operational services.\n\nIt also offers educational programs for industry professionals through its "AkaDREHMie" initiative.\n\nFounded in 2004 in Vienna by Ewald Moser with Sandra Hartbach as CEO since inception. As of 2024 it employs over 50 people and has annual revenue of approximately $7.2 million.\n\nThe company operates primarily within Austria/EU but serves international clients as well.\n\nSubsidiaries include "DREHM Strategies" (pharma marketing consulting) and "DREHM Communication & Innovation" (seminars/workshops).\n\nHeadquarters are located at Grünbergstraße 15/3/3, A‑1120 Vienna.\n\nNo evidence of public trading or acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DREHM Pharma.